학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 6건 | 목록
1~20
Academic Journal
de Jonge, Nick A ; Sikkens, Jonne J ; Zweegman, Sonja ; Beeker, Aart ; Ypma, Paula ; Herbers, Alexandra H ; Vasmel, Wies ; de Kreuk, Arne ; Coenen, Juleon L L M ; Lissenberg-Witte, Birgit ; Kramer, Mark H H ; van Agtmael, Michiel A ; Janssen, Jeroen J W M
In The Lancet Haematology August 2022 9(8):e563-e572
Academic Journal
Kuppen, Malou C P; Westgeest, Hans M; van den Eertwegh, Alphonsus J M; van Moorselaar, Reindert J A; van Oort, Inge M; Coenen, Juleon L L M; van den Bergh, A C M Fons; Mehra, Niven; Somford, Diederik M; Bergman, Andre M; Ten Bokkel Huinink, Daan; Fossion, Laurent; Geenen, Maud M; Hendriks, Mathijs P; van de Luijtgaarden, Addy C M; Polee, Marco B; Weijl, Nir I; van de Wouw, Agnes J; de Wit, Ronald; Uyl-de Groot, Carin A; Gerritsen, Winald R
Kuppen, M C P, Westgeest, H M, van den Eertwegh, A J M, van Moorselaar, R J A, van Oort, I M, Coenen, J L L M, van den Bergh, A C M F, Mehra, N, Somford, D M, Bergman, A M, Ten Bokkel Huinink, D, Fossion, L, Geenen, M M, Hendriks, M P, van de Luijtgaarden, A C M, Polee, M B, Weijl, N I, van de Wouw, A J, de Wit, R, Uyl-de Groot, C A & Gerritsen, W R 2021, 'Real-world Outcomes of Sequential Androgen-receptor Targeting Therapies with or Without Interposed Life-prolonging Drugs in Metastatic Castration-resistant Prostate Cancer : Results from the Dutch Castration-resistant Prostate Cancer Registry', European Urology Oncology, vol. 4, no. 4, pp. 618-627. https://doi.org/10.1016/j.euo.2019.09.005
European Urology Oncology, 4, 4, pp. 618-627
European Urology Oncology, 4, 4, pp. 618-627
Academic Journal
Westgeest HM; Department of Internal Medicine, Amphia Hospital, Breda, the Netherlands.; Kuppen MCP; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands.; van den Eertwegh FAJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.; van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, the Netherlands.; Coenen JLLM; Department of Oncology, Isala, Zwolle, the Netherlands.; van Moorselaar JRJA; Department of Urology, Amsterdam UMC, Vrije Universiteit, Amsterdam, the Netherlands.; Aben KKH; Department of Health Evidence, and Radboud University Medical Center, Nijmegen, the Netherlands.; Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands.; Bergman AM; Division of Medical Oncology, the Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.; Huinink DTB; Department of Internal Medicine, Diakonessenhuis, Utrecht, the Netherlands.; van den Bosch J; Department of Internal Medicine, Albert Schweitzer Ziekenhuis, Dordrecht, the Netherlands.; Hendriks MP; Department of Internal Medicine, Northwest Clinics, Alkmaar, the Netherlands.; Lampe MI; Department of Urology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.; Lavalaye J; Department of Nuclear Medicine, St Antonius Hospital, Nieuwegein, the Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Smilde TJ; Department of Internal Medicine, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands.; Somford RDM; Department of Urology, Canisius Wilhelmina Hospital, Nijmegen, the Netherlands.; Tick L; Department of Internal Medicine, Maxima Medical Center, Eindhoven, the Netherlands.; Weijl NI; Department of Internal Medicine, MCH-Bronovo Hospital, 's-Gravenhage, the Netherlands.; van de Wouw YAJ; Department of Internal Medicine, VieCuri Medical Center, Venlo, the Netherlands.; Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, the Netherlands.; Groot CAU; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, the Netherlands.
Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 9808462 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-7740 (Electronic) Linking ISSN: 15577740 NLM ISO Abbreviation: J Palliat Med Subsets: MEDLINE
Academic Journal
Zweegman, Sonja; van der Holt, Bronno; Mellqvist, Ulf-Henrik; Salomo, Morten; Bos, Gerard M J; Levin, Mark-David; Visser-Wisselaar, Heleen; Hansson, Markus; van der Velden, Annette W G; Deenik, Wendy; Gruber, Astrid; Coenen, Juleon L L M; Plesner, Torben; Klein, Saskia K; Tanis, Bea C; Szatkowski, Damian L; Brouwer, Rolf E; Westerman, Matthijs; Leys, M Rineke B L; Sinnige, Harm A M; Haukås, Einar; van der Hem, Klaas G; Durian, Marc F; Mattijssen, E Vera J M; van de Donk, Niels W C J; Stevens-Kroef, Marian J P L; Sonneveld, Pieter; Waage, Anders
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M B L, Sinnige, H A M, Haukas, E, van der Hem, K G, Durian, M F, Mattijssen, E J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, 'Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma', Blood, vol. 127, no. 9, pp. 1109-1116. https://doi.org/10.1182/blood-2015-11-679415
Blood, 127, 9, pp. 1109-16
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M R B L, Sinnige, H A M, Haukås, E, van der Hem, K G, Durian, M F, Mattijssen, E V J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
Blood, 127, 9, pp. 1109-16
Zweegman, S, van der Holt, B, Mellqvist, U-H, Salomo, M, Bos, G M J, Levin, M-D, Visser-Wisselaar, H, Hansson, M, van der Velden, A W G, Deenik, W, Gruber, A, Coenen, J L L M, Plesner, T, Klein, S K, Tanis, B C, Szatkowski, D L, Brouwer, R E, Westerman, M, Leys, M R B L, Sinnige, H A M, Haukås, E, van der Hem, K G, Durian, M F, Mattijssen, E V J M, van de Donk, N W C J, Stevens-Kroef, M J P L, Sonneveld, P & Waage, A 2016, ' Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma ', Blood, vol. 127, no. 9, pp. 1109-1116 . https://doi.org/10.1182/blood-2015-11-679415
Academic Journal
Westgeest HM; Department of Internal Medicine, Amphia Ziekenhuis, Breda, The Netherlands. Electronic address: hwestgeest@amphia.nl.; Kuppen MCP; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, The Netherlands.; van den Eertwegh AJM; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Vrije Universiteit, Amsterdam, The Netherlands.; de Wit R; Department of Medical Oncology, Erasmus MC Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.; Coenen JLLM; Department of Internal Medicine, Isala, Zwolle, The Netherlands.; van den Berg HPP; Department of Internal Medicine, Tergooi Ziekenhuizen, Hilversum, The Netherlands.; Mehra N; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.; van Oort IM; Department of Urology, Radboud University Medical Center, Nijmegen, The Netherlands.; Fossion LMCL; Department of Urology, Maxima Medisch Centrum, Veldhoven, The Netherlands.; Hendriks MP; Department of Internal Medicine, Northwest Clinics, Alkmaar, The Netherlands.; Bloemendal HJ; Department of Internal Medicine, Meander Medisch Centrum, Amersfoort, The Netherlands.; van de Luijtgaarden ACM; Department of Internal Medicine, Reinier de Graaf Gasthuis and Reinier Haga Prostate Cancer Centre, Delft, The Netherlands.; Ten Bokkel Huinink D; Department of Internal Medicine, Diakonessenhuis, Utrecht, The Netherlands.; van den Bergh ACMF; Department of Radiation Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; van den Bosch J; Department of Internal Medicine, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands.; Polee MB; Department of Internal Medicine, Medical Center, Leeuwarden, The Netherlands.; Weijl N; Department of Internal Medicine, MCH-Bronovo Ziekenhuis, 's-Gravenhage, The Netherlands.; Bergman AM; Division of Internal Medicine (MOD) and Oncogenomics, The Netherlands Cancer Institute Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Uyl-de Groot CA; Institute for Medical Technology Assessment, Erasmus School of Health Policy and Management, Rotterdam, The Netherlands.; Gerritsen WR; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Academic Journal
Bouman-Wammes EW; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands. Electronic address: e.bouman@vumc.nl.; van den Berg HP; Department of Medical Oncology, Tergooi Hospital, Hilversum, The Netherlands.; de Munck L; Department of Research, Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.; Beeker A; Department of Medical Oncology, Spaarne Gasthuis, Hoofddorp, The Netherlands.; Smorenburg CH; Department of Medical Oncology, Antoni van Leeuwenhoek, Amsterdam, The Netherlands.; Vervenne WL; Department of Medical Oncology, Deventer ziekenhuis, Deventer, The Netherlands.; Coenen JLLM; Department of Medical Oncology, Isala kliniek, Zwolle, The Netherlands.; Verheul HMW; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.; Gerritsen WR; Department of Medical Oncology, Radboud UMC, Nijmegen, The Netherlands.; Van den Eertwegh AJM; Department of Medical Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005373 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0852 (Electronic) Linking ISSN: 09598049 NLM ISO Abbreviation: Eur J Cancer Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Coenen, Juleon L L M
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어